Aquestive Therapeutics, Inc. (AQST) › Net IncomeAquestive Therapeutics, Inc. (AQST) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$8.94M2018: -$61.38M2019: -$66.25M2020: -$55.78M2021: -$70.54M2022: -$54.41M2023: -$7.87M2024: -$44.14M2025: -$83.78M-$83.78M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$83.78M-89.8%2024-$44.14M-460.8%2023-$7.87M+85.5%2022-$54.41M+22.9%2021-$70.54M-26.5%2020-$55.78M+15.8%2019-$66.25M-7.9%2018-$61.38M-586.3%2017-$8.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share